151 related articles for article (PubMed ID: 9624485)
1. Novel antibiotic susceptibility tests by the ATP-bioluminescence method using filamentous cell treatment.
Hattori N; Nakajima MO; O'Hara K; Sawai T
Antimicrob Agents Chemother; 1998 Jun; 42(6):1406-11. PubMed ID: 9624485
[TBL] [Abstract][Full Text] [Related]
2. Postantibiotic effect of beta-lactam antibiotics on Escherichia coli evaluated by bioluminescence assay of bacterial ATP.
Hanberger H; Nilsson LE; Kihlström E; Maller R
Antimicrob Agents Chemother; 1990 Jan; 34(1):102-6. PubMed ID: 2183707
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antimicrobial susceptibility for beta-lactams using the Etest method against clinical isolates from 100 medical centers in Japan (2006).
Ishii Y; Tateda K; Yamaguchi K;
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):177-83. PubMed ID: 17931820
[TBL] [Abstract][Full Text] [Related]
5. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
6. A two-hour antibiotic susceptibility test by ATP-bioluminescence.
March Rosselló GA; García-Loygorri Jordán de Urries MC; Gutiérrez Rodríguez MP; Simarro Grande M; Orduña Domingo A; Bratos Pérez MÁ
Enferm Infecc Microbiol Clin; 2016; 34(6):334-9. PubMed ID: 25979598
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program.
Jia P; Zhu Y; Zhang H; Cheng B; Guo P; Xu Y; Yang Q
BMC Microbiol; 2022 Oct; 22(1):234. PubMed ID: 36182895
[TBL] [Abstract][Full Text] [Related]
8. Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations.
Chow AW; Wong J; Bartlett KH; Shafran SD; Stiver HG
Antimicrob Agents Chemother; 1989 Aug; 33(8):1368-72. PubMed ID: 2508546
[TBL] [Abstract][Full Text] [Related]
9. Performance of Vitek 2 in antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates with different mechanisms of beta-lactam resistance.
Mazzariol A; Aldegheri M; Ligozzi M; Lo Cascio G; Koncan R; Fontana R
J Clin Microbiol; 2008 Jun; 46(6):2095-8. PubMed ID: 18434562
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
Philippon A
Chemioterapia; 1985 Dec; 4(6):424-8. PubMed ID: 3938346
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial susceptibility testing for Mycobacterium tuberculosis by the bioluminescence assay of mycobacterial ATP using filamentous cell treatment].
Yamazaki T; Sato N; Yamashita K; Okazawa Y; Tanno K
Rinsho Byori; 2000 Feb; 48(2):167-73. PubMed ID: 10804821
[TBL] [Abstract][Full Text] [Related]
12. [Application of a millipore membrane transfer method to the study of the activity of 4 beta-lactams on Pseudomonas aeruginosa].
Denis C; Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
Pathol Biol (Paris); 1984 May; 32(5):415-20. PubMed ID: 6429614
[TBL] [Abstract][Full Text] [Related]
13. In vitro comparison of Pseudomonas aeruginosa isolates with various susceptibilities to aminoglycosides and ten beta-lactam antibiotics.
Wu DH; Baltch AL; Smith RP
Antimicrob Agents Chemother; 1984 Apr; 25(4):488-90. PubMed ID: 6428308
[TBL] [Abstract][Full Text] [Related]
14. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
Wang H; Chen MJ;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of beta-lactam antibiotics on gram-negative bacteria: initial killing, morphology and postantibiotic effect.
Hanberger H; Nilsson LE; Maller R; Nilsson M
Scand J Infect Dis Suppl; 1990; 74():118-23. PubMed ID: 2129063
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa isolated from corneal ulcer: susceptibility to antimicrobial agents tested alone or in combination.
Hu FR; Luh KT
J Formos Med Assoc; 1992 Feb; 91(2):190-4. PubMed ID: 1364217
[TBL] [Abstract][Full Text] [Related]
17. Synergistic activities of combinations of beta-lactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa.
Takahashi K; Kanno H
Antimicrob Agents Chemother; 1984 Nov; 26(5):789-91. PubMed ID: 6440482
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility testing quality control studies with fosfomycin tromethamine.
Fuchs PC; Barry AL; Brown SD
Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):538-40. PubMed ID: 9272392
[TBL] [Abstract][Full Text] [Related]
19. MICy: a Novel Flow Cytometric Method for Rapid Determination of Minimal Inhibitory Concentration.
Kállai A; Kelemen M; Molnár N; Tropotei A; Hauser B; Iványi Z; Gál J; Ligeti E; Kristóf K; Lőrincz ÁM
Microbiol Spectr; 2021 Dec; 9(3):e0090121. PubMed ID: 34878335
[TBL] [Abstract][Full Text] [Related]
20. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
Schröter G; Schrettenbrunner A; Strenzel I
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
